Caption Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,338,000
+61.8%
1,184,700
+278.6%
0.02%
+100.0%
Q4 2021$827,000
-15.6%
312,900
+15.9%
0.01%
-25.0%
Q3 2021$980,000
-49.3%
270,000
-39.3%
0.01%
-53.8%
Q2 2021$1,932,000
+1023.3%
445,000
+790.0%
0.03%
+550.0%
Q1 2021$172,00050,000
+24900.0%
0.00%
Q4 2020$0
-100.0%
200
-99.9%
0.00%
-100.0%
Q3 2020$336,000
+166.7%
140,000
+154.5%
0.01%
-20.0%
Q4 2018$126,00055,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders